King County Navigation Bar (text navigation at bottom)
Public Health - Seattle & King County
Site Directory

Public Health Webpage Directory

Public Health Center & Office Locations
For Care Providers

Health Advisories & Resources
For Educators

Health Educators Toolbox
About Us

History & Profile

Jobs

Employee Directory

Contact HIV/AIDS

Info on HIV/AIDS:

206-205-7837
TTY: 206-296-4843
Toll-free: 800-678-1595

Administration:

206-296-4649

HIV/STD Testing

HIV/STD Hotline:

206-205-7837 or
Toll-free: 800-678-1595
11:00 am to 4:00 pm
Monday - Friday for
testing information, resources and referrals

Subscribe to Free Email Alerts!

Click here to learn more
magnifying glass Advanced Search
Search Tips
Home » HIV/AIDS Program » Literature bibliographies » January - February 2003
HIV/AIDS Program
Bibliographies for January - February 2003
Men Who Have Sex With Men

1. Gillmore MR, Morrison DM, Leigh BC, et al. Does "High = High Risk"? An Event-Based Analysis of the Relationship Between Substance Use and Unprotected Anal Sex Among Gay and Bisexual Men. AIDS & Behavior, Dec 2002; 6(4): 361-370.
2. Stueve A, O'Donnell L, Duran R, et al. Being High and Taking Sexual Risks: Finding From a Multi-site Survey of Urban Young Men Who Have Sex With Men. AIDS Education and Prevention , 2002; 14(6): 482-495.
3. HIV/AIDS Risk in Young Men Who Have Sex with Men Who Do Not Disclose Their Sexual Orientation --- Six U.S. Cities, 1994 -- 2000. MMWR, February 7, 2003; 52(05): 81-85.
4. Choi K, Han C, Hudes E, Kegeles S. Unprotected Sex and Associated Risk Factors Among Young Asian and Pacific Islander Men Who Have Sex with Men. AIDS Education and Prevention, 2002; 14(6): 472-481.
5. O'Donnell L, Agronick G, Doval A, et al. Ethnic and Gay Community Attachments and Sexual Risk Behavior Among Urban Latino Young Men Who Have Sex with Men. AIDS Education and Prevention, 2002; 14(6): 457-471.
6. Cáceres C. HIV Among Gay and Other Men who Have Sex with Men in Latin America and the Caribbean: a Hidden Epidemic? AIDS, 2002; 16(suppl 3): S23-S33.
Women

7. Schillinger J, Kissinger P, Calvet H, et al. Patient-Delivered Partner Treatment with Azithromycin to Prevent Repeated Chlamydia Trachomatis Infection Among Women. Sexually Transmitted Diseases, January 2003; 30(1): 49-56.
8. Kwakwa H, Ghobrial M. Female-to-female Transmission of Human Immunodeficiency Virus. (Brief Report) Clinical Infectious Diseases, February 2003; 36: e40-1.
9. Ness R, Hillier S, Richter H, et al. Why Women Douche and Why they May or May Not Stop. Sexually Transmitted Diseases, January 2003; 30(1): 71-74.
10. Kiddugavu M, Makumbi F, Wawer M, et al. Hormonal Contraceptive Use and HIV-1 Infection in a Population -based Cohort in Rakai, Uganda. AIDS, 2003; 17(2): 233-240.
11. Ickovics J, Beren S, Grigorenko E, et al. Pathways of Risk: Race, Social Class, Stress, and Coping as Factors Predicting Heterosexual Risk Behaviors for HIV Among Women. AIDS and Behavior, December 2002; 6(4): 339-350.
12. Kim A, Page-Shafer K, Ruiz J, et al. Vulnerability to HIV Among Women Formerly Incarcerated and Women with Incarcerated Sexual Partners. AIDS and Behavior, December 2002; 6(4): 331-338.
13. Jemmott L, Brown E. Reducing HIV Sexual Risk Among African American Women Who Use Drugs: Hearing Their Voices. Journal of the Association of Nurses in AIDS Care, Febuary 2003; 14(1): 19-26.
14. Harris R, Sharps P, Allen K, et al. The Interrelationship Between Violence, HIV/AIDS, and Drug Use in Incarcerated Women. JANAC, February 2003; 14(1): 27-40.
Harm Reduction and Drug Use

15. Swanson J, Cooper A. Dangerous Liaison: Club Drug Use and HIV/AIDS. IAPAC Monthly, December 2002; 330-338.
16. Macalino G, Celentano D, Latkin C et al. Risk Behaviors by Audio Computer-Assisted Self-Interviews Among HIV-Seropositive Injection Drug Users. AIDS Education and Prevention, 2002;14(5): 367-378.
17. Wood E, Kerr T, Spittal P. The Potential Public Health and Community Impacts of Safer Injecting Facilities: Evidence From a Cohort of Injection Drug Users. Journal of Acquired Immune Deficiency Syndromes, 2003; 32: 2-8.
18. Bouhnik D, Chesney M, Carrieri P et al. Nonadherence Among HIV-Infected Injecting Drug Users: The Impact of Social Instability. JAIDS, 2002; 31: S149-S153.
19. Carib K, Spittal P, Wood E et al. Risk Factors for Elevated HIV Incidence Among Aboriginal Injection Drug Users in Vancouver. Canadian Medical Association Journal, January 7, 2003; 168(1): 19-24.
20 Henderson L, Vlahov D, Celentano D, et al. Readiness for Cessation of Drug Use Among Recent Attendees and Non-attendees of a Needle Exchange Program. JAIDS, 2003; 32:229-237.
21. Rodriguez C, Marques L, Touze G. HIV and Injection Drug use in Latin America. AIDS, 2002; 16(suppl 3): s34-s41.
Sexually Transmitted Disease

22. Engelberg R, Carrell D, Krantz E, et al. Natural History of Genital Herpes Simplex Virus Type 1 Infection. Sexually Transmitted Diseases Feb 2003; 30(2): 174-177.
23. Sauder D, Skinner R, Fox T, et al. Topical Imiquimod 5% Cream as an Effective Treatment for External Genital and Perianal Warts in Different Patient Populations. Sexually Transmitted Diseases, February 2003; 30(2): 124-128.
24. Ginocchio R, Veenstra D, Connell F, et al. The Clinical and Economic Consequences of Screening Young Men for Genital Chlamydial Infection. Sexually Transmitted Diseases, February 2003; 30(2): 99-106.
25. Rietmeijer C, Bull S, McFarlane, M, et al. Risks and Benefits of the Internet for Populations at Risk for Sexually Transmitted Infections (STIs). Sexually Transmitted Diseases, January 2003; 30(1): 15-19.
26. Kassutto S, Sax P. HIV and Syphilis Coinfection: Trends and Interactions. AIDS Clinical Care, February 2003; 15(2): 9-15.
27. Crosby R, DiClemente R, Wingood G, et al. Infrequent Parental Monitoring Predicts Sexually Transmitted Infections Among Low-Income African American Female Adolescents. Arch Pediatr Adolesc Med, February 2003; 157: 169-173.
Prevention / Education

28. Ross M, Essien J, Williams M, et al. Concordance Between Sexual Behavior and Sexual Identity in Street Outreach Samples of Four Racial/Ethnic Groups. Sexually Transmitted Diseases, February 2003; 30(2): 110-113.
29. Paxton S. The Impact of Utilizing HIV-Positive Speakers in AIDS Education. AIDS Education and Prevention, 2003; 14(4): 282-294.
30 Fitch T, Stine C, Hager D, et al. Condom Effectiveness: Factors That Influence Risk Reduction. Sexually Transmitted Diseases, December 2002; 29(12): 811-817.
31. Semaan S, Lauby J, Liebman J. Street and Network Sampling in Evaluation Studies of HIV Risk-Reduction Interventions. AIDS Reviews, 2002; 4: 213-223.
32. Lagarde E, Dirk T, Puren A, et al. Acceptability of Male Circumcision as a Tool for Preventing HIV Infection in a Highly Infected Community in South Africa. AIDS, 2003; 17: 89-95.
33. Witkin A, Rotheram-Borus M, Milburn N, et al. Comprehensive Versus Abstinence-Only Sex Education: What Works? FOCUS January 2003; 18(2): 1-8.
Prisons

34. Krebs C, Simmons M, et al. Intraprison HIV Transmission: An Assessment of Whether It Occurs, How It Occurs, and Who Is at Risk. AIDS Education and Prevention, 2002; 14: 53-64.
35. Ehrmann, T. Community-Based Organizations and HIV Prevention for Incarcerated Populations: Three HIV Prevention Program Models. AIDS Education and Prevention, 2002; 17: 89-95.
36. May J, Williams E. Acceptability of Condom Availability in a US Jail. AIDS Education and Prevention, 2002; 14: 85-91.
37. Mertz K, Voigt R, Hutchins K, et al. Findings From STD Screening of Adolescents and Adults Entering Corrections Facilities. Sexually Transmitted Diseases, December 2002; 29(12): 834-839.
Living with HIV

38. Heckman T, Silverthorn M, Waltje A, et al. HIV Transmission Risk Practices in Rural Persons Living With HIV Disease. Sexually Transmitted Diseases, February 2003; 30(2): 134-136.
39. Lee R, Kochman A, Sikkema K. Internalized Stigma Among People With HIV-AIDS. AIDS And Behavior, December 2002; 6(4): 309-319.
40. Golin C, Isasi F, Bontempi B, et al. Secret Pills: HIV-Positive Patients' Experiences Taking Antiretroviral Therapy in North Carolina. AIDS Education and Prevention, 2002; 14(4): 318-329.
Anti Retroviral Treatment

41. Jensen-Fangel S, Pedersen L, Pedersen C, et al. The Effect of Race/Ethnicity on the Outcome of Highly Active Antiretorviral Therapy for Human Immunodeficiency Virus Type 1-Infected Patients. Clinical Infectious Diseases, 2002; 35: 1541-1548.
42. Tuldra A, Wu W. Interventions to Improve Adherence to Antiretroviral Therapy. JAIDS, December 15, 2002; 31(Suppl 3): S154-S157.
43. Ammassari A, Trotta M, Murri R, et al. Correlates and Predictors of Adherence to Highly Active Antiretroviral Therapy: Overview of Published Literature. JAIDS, December 15, 2002; 31(suppl 3): S123-S127.
44. Barriero P, Garcia-Benayas T, Soriano V, et al. Simplification of Antiretroviral Treatment - How to Sustain Success, Reduce Toxicity and Ensure Adherence Avoiding Pl Use. AIDS Reviews, 2002; 4: 233-241.
45. Galvao J. Access to Aniretroviral Drugs in Brazil. The Lancet, December 7, 2002; 360: 1862-1865.
46. Nonoccupational HIV PEP Task Force. Nonocuppational Human Immunodeficiency Virus Postexposure Prophylaxis Guidelines For Rhode Island Healthcare Practitioners. 1-26. Available on-line at: www.healthri.org/disease/NPEPFinalDraftJuly26.pdf, www.healthri.org/media/020925a.htm
Counseling, Testing, and Partner Notification

47. Phillips K, Bayer R, Chen J. New Centers for Disease Control and Prevention's Guidelines on HIV Counseling and Testing for the General Population and Pregnant Women. JAIDS, February 1, 2003; 32(2): 182-191.
48 Wright K. Rapid Test Time. POZ, February/March 2003; 31(3): 34-37.
49. Golden M, Hopkins S, Morris M, et al. Support Among Persons Infected With HIV For Routine Health Department Contact For HIV Partner Notification. JAIDS , February 1, 2003; 32(2): 196-202.
50. Kissinger P, Niccolai L, Magnus M, et al. Partner Notification for HIV and Syphilis. Sexually Transmitted Diseases, January 2003; 30(1): 75-82.
51. Hoxworth T, Spencer N, Peterman T, et al. Changes in Partnerships and HIV Risk Behaviors After Partner Notification. Sexually Transmitted Diseases, January 2003; 31(1): 83-88.
52. Potterat J. Partner Notification for HIV: Running Out of Excuses. (Editorial) Sexually Transmitted Diseases, January 2003; 89-90.
Hepatitis

53. Sulkowski M, Thomas D. Hepatitis C in the HIV-Infected Person. Annals of Internal Medicine, February 4, 2003; 138(3): 197-207.
54. Romanowski B, Preiksaitis J, Campbell P, et al. Hepatitis C Seroprevalence and Risk Behaviors in Patients Attending Sexually Transmitted Disease Clinics. Sexually Transmitted Diseases, January 2003; 30(1): 33-38.
55. Thio C, Seaberg E, Lkolasky R, et al. HIV-1 Hepatitis B Virus, and Risk of Liver-Related mortality in the Multicenter Cohort Study (MACS). The Lancet, December 14, 2002; 360: 1921-1926.
Miscellaneous

56. Bronfman M, Leyva R, Rueda N, et al. Mobile Populations and HIV/AIDS in Central America and Mexico: Research for Action. AIDS, 2002; 16(suppl 3): S42-S49.
57. Calleja J, Walker N, Cuchi P, et al. Status of the HIV/AIDS Epidemic and Methods to Monitor it in the Latin America and Caribbean Region. AIDS, 2002; 16(suppl 3): S3-S12.
58. Holtzman D, Chen S, Zhang S, et al. Current HIV/AIDS-Related Knowledge, Attitudes, and Practices Among the General Population in China: Implications for Action. Sciences AIDS Prevention and Vaccine Research Site, January 10, 2003; 3(1): 1-5. Available on line at: http://aidscience.org/Articles/aidscience028.asp. Accessed April 4, 2003.
59. Coleman C. Transmission of HIV Infection Among Older Adults: A Population at Risk. Journal of the Association of Nurses in AIDS Care, January/February 2003; 14(1): 82-85.
60. Blumberg S, Dickey, W. Prevalence of HIV Risk Behaviors, Risk Perceptions, and Testing Among US Adults With Mental Disorders. Journal of Acquired Immune Deficiency Syndromes, 2003; 32: 77-79.
61. Goodnough L, Shander A, Brecher M. Transfusion Medicine: Looking to the Future. The Lancet, January 11, 2003; 36: 161-169.

Updated: Monday, February 13, 2006 at 10:26 AM

All information is general in nature and is not intended to be used as a substitute for appropriate professional advice. For more information please call (206) 296-4600 (voice) or TTY Relay: 711. Mailing address: ATTN: Communications Team, Public Health - Seattle & King County, 401 5th Ave., Suite 1300, Seattle, WA 98104 or click here to email us.

King County | News | Services | Comments | Search

Links to external sites do not constitute endorsements by King County.
By visiting this and other King County web pages, you expressly agree to be bound by terms
and conditions of the site. The details.